GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Brain Scientific Inc (OTCPK:BRSF) » Definitions » Market Cap

Brain Scientific (Brain Scientific) Market Cap : $0.93 Mil (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Brain Scientific Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Brain Scientific's share price for the quarter that ended in Dec. 2022 was $8.5. Brain Scientific's Shares Outstanding (EOP) for the quarter that ended in Dec. 2022 was 1.24 Mil. Therefore, Brain Scientific's market cap for the quarter that ended in Dec. 2022 was $10.56 Mil.

Brain Scientific's quarterly market cap declined from Jun. 2022 ($17.92 Mil) to Sep. 2022 ($12.24 Mil) and declined from Sep. 2022 ($12.24 Mil) to Dec. 2022 ($10.56 Mil).

Brain Scientific's annual market cap stayed the same from . 20 ($0.00 Mil) to Dec. 2021 ($0.00 Mil) but then increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($10.56 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Brain Scientific's Enterprise Value for Today is $3.05 Mil.


Brain Scientific Market Cap Historical Data

The historical data trend for Brain Scientific's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brain Scientific Market Cap Chart

Brain Scientific Annual Data
Trend Dec21 Dec22
Market Cap
- 10.56

Brain Scientific Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Market Cap Get a 7-Day Free Trial - - 17.92 12.24 10.56

Competitive Comparison of Brain Scientific's Market Cap

For the Medical Devices subindustry, Brain Scientific's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brain Scientific's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Brain Scientific's Market Cap distribution charts can be found below:

* The bar in red indicates where Brain Scientific's Market Cap falls into.



Brain Scientific Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Brain Scientific's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )=Share Price (A: Dec. 2022 )*Shares Outstanding (EOP) (A: Dec. 2022 )
=$8.5*1.24265
=$10.56

Brain Scientific's Market Cap for the quarter that ended in Dec. 2022 is calculated as

Market Cap (Q: Dec. 2022 )=Share Price (Q: Dec. 2022 )*Shares Outstanding (EOP) (Q: Dec. 2022 )
=$8.5*1.24265
=$10.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brain Scientific  (OTCPK:BRSF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Brain Scientific Market Cap Related Terms

Thank you for viewing the detailed overview of Brain Scientific's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Brain Scientific (Brain Scientific) Business Description

Traded in Other Exchanges
N/A
Address
6700 Professional Parkway, Lakewood Ranch, FL, USA, 34240
Brain Scientific Inc is a medical technology company with two product lines: neurology products are medical devices and software products designed for the neurology market. and motion products are small piezoelectric motors that are designed for and expected to have valuable and beneficial uses as motors within medical devices and devices outside of the medical technology industry.
Executives
Morgan C. Frank 10 percent owner 2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Manchester Management Co Llc 10 percent owner 3 WEST HILL PLACE, BOSTON MA 02110
Manchester Explorer, L.p. 10 percent owner MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114
James E Besser 10 percent owner 3 WEST HILL PLACE, BOSTON MA 02114
Jeb Partners, L.p. 10 percent owner MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, BOSTON MA 02114
Manchester Management Pr, Llc 10 percent owner 3 WEST HILL PLACE, BOSTON MA 02114
Donald S Mackenzie director 5251 FISHER ISLAND DRIVE, MIAMI BEACH FL 33109
Thomas Olivier director C/O ARROWROOT ACQUISITION CORP., 4553 GLENCOE AVE SUITE 200, MARINA DEL REY CA 90292
Farid Anthony officer: Chief Technology Officer 12041 NW 49TH DRIVE, CORAL SPRINGS FL 33076
Daniel Danny Cloutier director 1200 MC GILL COLLEGE AVENUE, SUITE 1100, MONTREAL A8 H3G4G7
Bonnie-jeanne Gerety officer: Chief Financial Officer 5255 SOUTH TRIMBLE RD, SANDY SPRINGS GA 30342
Hassan Kotob director, 10 percent owner, officer: Chief Executive Officer 125 WILBUR PLACE, SUITE 170, C/O BRAIN SCIENTIFIC INC., BOHEMIA NY 11716
Mark Corrao officer: Chief Financial Officer 531 AIRPORT NORTH OFFICE PARK, FORT WAYNE IN 46825
Boris Goldstein director, 10 percent owner, officer: Chairman of the Board & EVP 45 WEST34 ST. 800, NEW YORK NY 10001
Nickolay V. Kukekov director 4524 WESTWAY AVE, DALLAS TX 75205